Catalyst Wire Dossier Catalyst Wire Dossier

β2-agonist

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for β2-agonist, covering 2018-01-26 to 2018-01-26. Get the full timeline:

Most recent: Clinical Trial Update: β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation [Phase 3]

See pricing